A four-year pilot project, which would permit the use of cannabis for medicinal purposes in Iceland, has been proposed by policymakers.
Following a debate in Alþingi [Icelandic parliament] last week, officials have proposed a four-year pilot project to permit the use of medical cannabis, as well as the cultivation, production, and distribution of cannabis-based products for medicinal use.
If approved, the Ministry of Health will work with the Minister of Culture and Trade to establish a working group to prepare a bill allowing companies to apply for licenses to produce and distribute cannabis medicines.
The bill would need to be presented by the ministry by December 21, with the four-year pilot program expected to begin on January 1, 2024.
Currently, the only cannabis-based medicine which can be legally prescribed in Iceland is Sativex, which contains isolated forms of CBD and THC and is used as a treatment for spasticity associated with multiple sclerosis (MS) and muscular dystrophy. However, access to Sativex is strictly regulated and can only be prescribed by licensed neurologists. CBD products are legal in Iceland, provided they are THC-free.
Read the entire article at Cannabis Health News